BIOMAT Database Logo BIOMAT Database Logo

Temozolomide in glioblastoma multiforme of the elderly. 2002

Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
Division of Medical Oncology, Azienda Ospedale, Università di Padova.

UI MeSH Term Description Entries
D008297 Male Males
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D003606 Dacarbazine An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564) DTIC,5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide,Biocarbazine,DIC,DTIC-Dome,Decarbazine,Deticene,Dimethyl Imidazole Carboxamide,Dimethyl Triazeno Imidazole Carboxamide,ICDT,NSC-45388,Carboxamide, Dimethyl Imidazole,DTIC Dome,DTICDome,Imidazole Carboxamide, Dimethyl,NSC 45388,NSC45388
D005260 Female Females
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077204 Temozolomide A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA. 8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one,CCRG 81045,CCRG-81045,M&B 39831,M&B-39831,Methazolastone,NSC 362856,NSC-362856,TMZ-Bioshuttle,TMZA-HE,Temodal,Temodar,Temozolomide Hexyl Ester,CCRG81045,M&B39831,NSC362856,TMZ Bioshuttle
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
Temozolomide resistance in glioblastoma multiforme.
September 2016, Genes & diseases,
Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
Radiotherapy with concurrent or sequential temozolomide in elderly patients with glioblastoma multiforme.
April 2012, Journal of medical imaging and radiation oncology,
Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
Temozolomide presents breakthrough in glioblastoma multiforme treatment.
April 1999, Pharmaceutical science & technology today,
Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
The efficacy of temozolomide for recurrent glioblastoma multiforme.
February 2013, European journal of neurology,
Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
Temozolomide and thalidomide in the treatment of glioblastoma multiforme.
January 2007, Anticancer research,
Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
The role of temozolomide in newly-diagnosed glioblastoma multiforme.
June 2008, British journal of neurosurgery,
Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.
May 2012, Expert review of anticancer therapy,
Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients.
March 2008, International journal of radiation oncology, biology, physics,
Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?
June 2010, American journal of clinical oncology,
Alba A Brandes, and Francesca Vastola, and Umberto Basso, and Lara M Pasetto, and Mario Ermani, and Franco Berti, and Antonino Rotilio, and Pietro Amistà, and Renato Scienza, and Silvio Monfardini
Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme.
June 2017, Cureus,
Copied contents to your clipboard!